For example, p-tau231 has been shown to be the first p-tau residue abnormally emerging across the AD continuum, a unique feature allowing the earliest confirmation of underlying AD pathophysiological changes [30–33]. The gene discussed is MAPT; the disease is Alzheimer disease.